Amrutanjan Health Care Q1 FY27 Results

Net Sales: ₹102.97 crore
Profit After Tax: ₹4.37 crore

Reader Takeaway: Top-line growth driven by diversification; bottom-line impacted by one-time provision and cost pressures.

What just happened

Amrutanjan Health Care reported its financial results for the first quarter of fiscal year 2027 (Q1 FY27). Net sales increased by 9.48% year-on-year to ₹102.97 crore, up from ₹94.05 crore in Q1 FY26. However, Profit After Tax (PAT) saw a significant drop of 47.41%, falling to ₹4.37 crore from ₹8.31 crore in the same period last year.

Why this matters

The sales growth indicates continued demand for the company's products, particularly in newer segments like Women's Hygiene. The dip in PAT, however, warrants attention. Investors need to understand the impact of the one-time provision and the ongoing pressures on profitability from rising costs and competitive dynamics in certain segments.

The backstory

The company has been focusing on diversifying its product portfolio beyond its traditional pain management offerings. This includes expanding into categories like women's hygiene with its Comfy brand, and other personal care items. The current results reflect both the success of these diversification efforts and challenges in its core business.

What changes now

The results highlight the company's strategy to grow through new product categories and capacity expansion, exemplified by the new sanitary napkin facility in Telangana. While the one-time provision is expected to clear the decks for future periods, investors will be watching how effectively the company manages operational costs and drives volume in its core pain relief segment.

Risks to watch

• Volume pressure in the core pain management category.
• Rising raw material and operational costs, exacerbated by geopolitical factors.
• Navigating new regulatory requirements in the beverage business.

Peer comparison

While specific direct peer results for Q1 FY27 are not detailed here, the company's performance in the pain management segment faces industry-wide volume challenges. Competitors in the women's hygiene segment are also likely experiencing growth, with market share dynamics being crucial.

Context metrics (time-bound)

• Net Sales grew 9.48% YoY to ₹102.97 crore in Q1 FY27.
• Profit Before Tax fell 46.24% YoY to ₹6.07 crore.
• Profit After Tax fell 47.41% YoY to ₹4.37 crore.
• An additional provision of ₹2.03 crore was made for a lease rent matter.
• Women’s Hygiene segment revenue was ₹36.36 crore, with Comfy contributing 33% of total revenue.
• Pain management segment saw a volume growth of -3.4%.
• New sanitary napkin facility in Telangana represents an investment of ₹150 crore.

What to track next

Investors should monitor the company's guidance for the full year, the ramp-up and performance of the new Telangana facility, and any impact from cost management strategies. Tracking the volume performance in the pain management category and the growth trajectory of newer segments like Women's Hygiene will be crucial.